tallózása szerző szerint "Bilecz, Ágnes"

1-3 / 3

DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells

Laengle J; Stift J; Bilecz, Ágnes; Wolf B; Beer A; Hegedűs, Balázs; Stremitzer S; Starlinger P; Tamandl D; Pils D; Bergmann M (2018)

Preclinical models indicate that DNA damage induces type I interferon (IFN), which is crucial for the induction of an anti-tumor immune response. In human cancers, however, the association between DNA damage and an immunogenic ...
MOLECULAR AND HISTOLPATHOLOGIC PROGNOSTIC FACTORS IN MALIGNANT PLEURAL MESOTHELIOMA

Bilecz, Ágnes (2020)
Vessel co-option is common in human lung metastases and mediates resistance to anti-angiogenic therapy in preclinical lung metastasis models

Bridgeman VL; Vermeulen PB; Foo S; Bilecz, Ágnes; Daley F; Kostaras E; Nathan MR; Wan E; Frentzas S; Schweiger T; Hegedűs, Balázs; Hoetzenecker K; Rényi-Vámos, Ferenc István; Kuczynski EA; Vasudev NS; Larkin J; Gore M; Dvorak HF; Paku, Sándor; Kerbel RS; Döme, Balázs; Reynolds AR (2017)

Anti-angiogenic therapies have shown limited efficacy in the clinical management of metastatic disease, including lung metastases. Moreover, the mechanisms via which tumours resist anti-angiogenic therapies are poorly ...

1-3 / 3

Keresés